Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DESSENNE : revenue, balance sheet and financial ratios

SELARL PHARMACIE DESSENNE is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in HENIN-BEAUMONT (62110), this company of category PME shows in 2024 a net income positive of 56 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - SELARL PHARMACIE DESSENNE (SIREN 842573248)
Kennzahl 2024 2023 2022 2021 2020 2019
Umsatz N/C N/C N/C N/C N/C N/C
Nettoergebnis 56 029 € 61 318 € 111 753 € 87 225 € 87 296 € 52 714 €
EBITDA N/C N/C N/C N/C N/C N/C
Nettomarge N/C N/C N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2024, SELARL PHARMACIE DESSENNE generates positive net income of 56 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 53 k€ -> 56 k€.

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

56 029 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 58%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

58.413%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

58.522%

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

43.9%

Entwicklung der Solvenzkennzahlen
SELARL PHARMACIE DESSENNE

Positionnement sectoriel

Debt ratio
58.41 2024
2022
2023
2024
Q1: 16.46
Méd: 58.47
Q3: 154.89
Good -6 pts über 3 Jahre

In 2024, the debt ratio of SELARL PHARMACIE DESSENNE (58.41) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
58.52% 2024
2022
2023
2024
Q1: 28.91%
Méd: 49.95%
Q3: 69.47%
Good +16 pts über 3 Jahre

In 2024, the financial autonomy of SELARL PHARMACIE DESSENNE (58.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 600.50. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

600.505

Entwicklung der Liquiditätskennzahlen
SELARL PHARMACIE DESSENNE

Positionnement sectoriel

Liquidity ratio
600.5 2024
2022
2023
2024
Q1: 129.47
Méd: 182.13
Q3: 260.78
Excellent

In 2024, the liquidity ratio of SELARL PHARMACIE DESSENNE (600.50) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positionnement de SELARL PHARMACIE DESSENNE dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DESSENNE is estimated at 782 206 € (range 544 716€ - 1 170 225€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
544k€ 782k€ 1170k€
782 206 € Range: 544 716€ - 1 170 225€
NAF 5 année 2024

Valuation method used

Net Income Multiple
56 029 € × 14.0x = 782 206 €
Range: 544 716€ - 1 170 225€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DESSENNE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DESSENNE

What is the revenue of SELARL PHARMACIE DESSENNE ?

The revenue of SELARL PHARMACIE DESSENNE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DESSENNE profitable?

Yes, SELARL PHARMACIE DESSENNE generated a net profit of 56 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DESSENNE ?

The headquarters of SELARL PHARMACIE DESSENNE is located in HENIN-BEAUMONT (62110), in the department Pas-de-Calais.

Where to find the tax return of SELARL PHARMACIE DESSENNE ?

The tax return of SELARL PHARMACIE DESSENNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DESSENNE operate?

SELARL PHARMACIE DESSENNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.